Previous Article | Next Article 
Molecular and Cellular Biology, March 2001, p. 2184-2191, Vol. 21, No. 6
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.6.2184-2191.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Distinct Functional Domains of Nibrin Mediate Mre11
Binding, Focus Formation, and Nuclear Localization
Ami
Desai-Mehta,
Karen M.
Cerosaletti, and
Patrick
Concannon*
Molecular Genetics Program, Virginia Mason
Research Center, Seattle, Washington 98101, and Department of
Immunology, University of Washington School of Medicine, Seattle,
Washington 98195
Received 31 May 2000/Returned for modification 10 August
2000/Accepted 22 December 2000
 |
ABSTRACT |
The inherited chromosomal instability disorder Nijmegen breakage
syndrome (NBS) results from truncating mutations in the
NBS1 gene, which encodes the protein nibrin. Nibrin is part
of a nuclear multiprotein complex that also contains the DNA repair
proteins Mre11 and Rad50. Upon irradiation, this complex
redistributes within the nucleus, forming distinct foci that
have been implicated as sites of DNA repair. In NBS cells, nibrin is
absent and Mre11 and Rad50 are cytoplasmic. In this study, the
interacting domains on nibrin and Mre11 were mapped using the yeast
two-hybrid system and expression of epitope-tagged constructs in
NBS fibroblasts. Deletion of the carboxy-terminal 101 amino acids of
nibrin eliminated its ability to interact with Mre11 and to complement
the radiation sensitivity of NBS cells. However, this truncated form of
nibrin could localize to the nucleus and form radiation-inducible foci. Expression of a carboxy-terminal 354-amino-acid fragment of nibrin was
sufficient to direct the nuclear localization of nibrin, as well as
that of Mre11 and Rad50. Despite providing some partial complementation of the radiation-sensitive phenotype, the
nibrin-Mre11-Rad50 complexes in these cells were unable to form foci.
These results indicate that nibrin directs not only the nuclear
localization of the nibrin-Mre11-Rad50 complexes but also
radiation-induced focus formation. However, direct interaction between
nibrin and Mre11 is required for normal cellular survival
postirradiation. Distinct domains of nibrin are required for each of
these functions, focus formation, nuclear localization, and Mre11 interaction.
 |
INTRODUCTION |
The autosomal recessive disorder
Nijmegen breakage syndrome (NBS) is characterized by microcephaly,
growth retardation, borderline mental retardation, humoral and cellular
immunodeficiency, chromosomal instability, radiation sensitivity, and
an increased incidence of malignancies, particularly those of lymphoid
origin (25). NBS cells cultured in vitro are deficient in
the response to treatment with DNA double-strand break (DSB)-inducing
agents such as ionizing radiation and radiomimetic compounds. These
defective responses include reduction in colony-forming ability
postirradiation, a failure to inhibit DNA synthesis in response to
acute doses of radiation (radioresistant DNA synthesis), and an
increased frequency of chromosomal aberrations (14, 24).
Positional cloning studies in NBS families and functional
complementation studies identified a single gene, NBS1, that
is mutated in most patients with NBS (19, 26).
The NBS1 gene is located on human chromosome 8q21 (6,
20, 22, 26) and encodes a ubiquitously expressed protein of 754 amino acids (aa) termed nibrin or p95. All known NBS1
mutations are clustered between nucleotides 657 and 1142 of the gene,
and all are predicted to truncate the nibrin protein. Most (90 to 95%)
of reported NBS patients are homozygous for one mutation (657del5); no
other mutation has been observed in more than one family. Nibrin is not
detectable by Western blotting in NBS cell lines, suggesting that most
mutations are null (4). However, the production of a
truncated protein product containing the amino-terminal end of nibrin
cannot be ruled out. This amino-terminal portion of nibrin contains two
adjacent and potentially functional domains, a forkhead-associated
(FHA) domain (11) and a breast cancer carboxy-terminal
(BRCT) domain (2), which have been observed previously in
other proteins involved in DNA damage responses or in cell cycle
checkpoint control.
In normal fibroblasts, nibrin is localized in the nucleus in
association with two additional proteins, Mre11 and Rad50, which participate in DNA DSB repair (4). Reciprocal
coimmunoprecipitation experiments indicate a strong physical
association between the three proteins (4, 18). Treatment
of cells with DSB-inducing agents, such as ionizing radiation, results
in a rapid association between Mre11 and damaged DNA within 30 min of
irradiation (21). At later times (8 to 12 h)
postirradiation, brightly staining foci containing nibrin, Mre11, and
Rad50 are apparent in the nuclei of 60 to 90% of exposed fibroblasts.
While such foci are also detectable in unirradiated cells, the average
number per cell and the frequency of cells with detectable foci
increases in response to irradiation (18). The function of
these irradiation-induced foci (IRIF) is unknown, but given the early
association of Mre11 with DSB's (21), these foci may
represent sites of ongoing repair or of unresolved breaks. In NBS
cells, which lack nibrin, Mre11 and Rad50 still interact, but complexes
containing these two proteins are confined to the cytoplasm and thus
cannot form nuclear foci (4).
In this study, we have mapped the sites of interaction between
the nibrin and Mre11 proteins in vitro using yeast two-hybrid analysis
and in vivo by expression of epitope- tagged constructs and coimmunoprecipitation. The abilities of in
vitro-constructed deletion mutants of nibrin to complement
the cellular phenotypes of NBS were assessed by transfection of
NBS cell lines.
 |
MATERIALS AND METHODS |
Cell lines.
The simian virus 40 (SV40)-transformed
fibroblast cell lines GM637 (Coriell Institute, Camden, N.J.) and
NBS-ILB1 (16) were grown in Dulbecco modified Eagle medium
(DMEM; Life Technologies Inc., Rockville, Md.) supplemented with
L-glutamine (Life Technologies), 15% fetal calf serum
(FCS; HyClone Laboratories Inc., Logan, Utah), penicillin (100 U/ml),
and streptomycin (100 µg/ml) (Life Technologies). NBS-ILB1 cells
infected with retroviral expression constructs (5) were
maintained in the above medium supplemented with G418 (500 µg/ml;
Life Technologies). The SV40-transformed fibroblast cell line MRC5
(12) was maintained in DMEM-F12 medium supplemented with
15% FCS, penicillin (100 U/ml), and streptomycin (100 µg/ml). Phoenix A retroviral packaging cells (P. Achacoso et al., unpublished data) were maintained in DMEM supplemented with 10% heat-inactivated FCS, penicillin (100 U/ml), and streptomycin (100 µg/ml). Cells were
grown at 37°C in 5% CO2.
Yeast two-hybrid analysis.
The nibrin 2,265-bp coding region
and five different 900- to 1,100-bp overlapping subfragments thereof
were cloned into the SalI site of plasmid pAS2-1 (Clontech
Laboratories Inc., Palo Alto, Calif.) that expresses the DNA-binding
domain of the Gal4 transcription factor. Smaller fragments of nibrin
were amplified and cloned in a similar manner. Individual cDNA clones
of Mre11 and five overlapping subfragments were generated using a
full-length IMAGE consortium cDNA clone of human MRE11
(645656; American Type Culture Collection) as template. The amplified
Mre11 fragments were cloned into the XhoI site of plasmid
pACT2 (Clontech), which expresses the activation domain of the Gal4
transcription factor. Other Mre11 subfragments were amplified and
cloned in a similar fashion.
Saccharomyces cerevisiae strain Y190 was contransformed with
nibrin and Mre11 expression plasmids. The transformants were selected
for growth on synthetic dropout (SD) medium lacking uridine, tryptophan, and leucine. Individual yeast clones selected for carrying
both plasmids were tested for histidine prototrophy by plating on SD
medium lacking uridine, tryptophan, leucine, histidine, and lysine and
supplemented with 30 mM 3-amino-1,2,4-triazole (Sigma Chemical Co., St.
Louis, Mo.). Activation of lacZ reporter gene expression was
determined by a
-galactosidase (
-Gal) filter lift assay
(1) and quantitated by a liquid assay (Pierce Chemical Co., Rockford, Ill.). For the latter assay, independent cotransformants (three to eight colonies) carrying both plasmids were grown overnight in selective liquid medium until log phase. Optical density at 600 nm
(OD600) of the test cultures was determined. Then 70 µl of each individual culture was dispensed in duplicate in individual wells of a 96-well plate, and 70 µl of reagent mix containing equal
volumes of 2×
-Gal assay buffer, and Y-PER reagent was added. The
reaction mixture was incubated at 30°C until the wells turned yellow;
the reaction was stopped by addition of 56 µl of 1 M sodium
carbonate, and the total reaction time was recorded. The plates were
centrifuged and absorbance of the supernatant was measured at 405 nm.
-Gal activity was calculated as 1,000 × A405/(t × V × OD600), where
t is time of incubation (in minutes) and V is
volume of cells used in the assay (in milliliters). Relative difference
in
-Gal activity was determined by dividing
-Gal activity of the
test sample by
-Gal activity of plasmid alone. All data presented
are averages of at least three independent colonies.
Retroviral gene expression.
The retroviral construct
expressing full-length nibrin (NBS1) was previously described
(5). For construction of the Nb652 retrovirus, we took
advantage of a spontaneous mutation (1958insA) that arises when
nibrin-containing plasmids are passaged in Escherichia coli
(5). A cDNA clone containing the 1958insA mutation was isolated from an Epstein-Barr virus-transformed B-cell cDNA library cloned in the pBK-CMV vector (Stratagene). The cDNA was subcloned into
the BamHI-XhoI sites of the pBS-SK vector
(Stratagene) for further manipulations. For in vivo expression, a
BamHI-NcoI (bp
62 to 2287) fragment of the
1958insA cDNA was cloned into the HpaI site of the pLXIN
retroviral construct (Clontech) upstream of the internal ribosome entry
site-neo gene cassette. For construction of nibrin fragment
5 retroviral constructs, NbFR5 and NbFR5.1 fragments were separately
subcloned into the pCMV-Tag3 vector (Stratagene, Cedar Creek, Tex.).
SalI-ApaI fragments containing the NbFR5 and
NbFR5.1 inserts with the Myc tag were blunted and cloned into the
HpaI site of the pLXIN retroviral vector. The 1958insA/pLXIN, NbFR5/pLXIN, and NbFR5.1/pLXIN constructs were introduced into NBS-ILB1 cells by retroviral gene transfer as described
elsewhere (5). Bulk-transformed cell lines were selected in G418 (1 mg/ml; Life Technologies).
Immunoprecipitation and immunoblotting.
Cell lysates were
prepared from 3 × 106 to 7 × 106
cells in cell lysis buffer (50 mM sodium phosphate [pH 7.2], 0.5%
Triton X-100, 2 mM EDTA, 2 mM EGTA, 25 mM sodium fluoride, 25 mM
glycerophosphate, 2 mM dithiothreitol, protease inhibitor cocktail
tablet [Roche Molecular Biochemicals, Indianapolis, Ind.]). Lysates
were sonicated for 3 min at 4°C and cleared by centrifugation. To
preclear cell lysates, 5 µg of whole mouse (Pierce) or rabbit (Zymed
Laboratories Inc., South San Francisco, Calif.) immunoglobulin G (IgG)
and 20 µl of GammaBind Plus-Sepharose beads (Amersham Pharmacia
Biotech Inc, Piscataway, N.J.) were added to the supernatant, and tubes were rocked for 1 h at 4°C; then the supernatant was removed, and antibody was added. For immunoprecipitation of Myc-tagged proteins,
hybridoma supernatant containing anti-Myc tag antibody 9E10
(9) was used. To immunoprecipitate nibrin, rabbit
polyclonal antinibrin antibody (Novus Biologicals, Littleton, Colo.)
was added at 1:3,000. After incubation on ice for 1 h, Sepharose
beads were added and the tubes were rocked for 1 h at 4°C. The
beads were washed four times with lysis buffer and resuspended in lysis buffer with loading dye. After boiling for 5 min, 20 µl of each sample was loaded per lane on a discontinuous sodium dodecyl
sulfate-polyacrylamide gel. Electrophoresis was carried out in a
Bio-Rad mini-PROTEAN II apparatus (Bio-Rad Laboratories, Hercules,
Calif.) using 1× protein gel running buffer containing 25 mM Tris, 192 mM glycine, and 0.1% sodium dodecyl sulfate at 100 V for 2 h.
Proteins were transferred to Immobilon P membranes (Millipore Corp.,
Bedford, Mass.) in transfer buffer with 25 mM Tris, 192 mM glycine, and 15% methanol at 30 V overnight at 4°C.
Nibrin, Mre11, and Rad50 proteins were detected by Western blot
analysis. Membranes were blocked with Tris-buffered saline
(pH 7.6)
containing 0.1% Tween 20 and 10% nonfat milk powder for
2 h at
room temperature and washed. Nibrin was detected using
the rabbit
polyclonal antinibrin antiserum (Novus) at 1:10,000.
Mre11 protein was
detected using anti-Mre11 monoclonal antibody
292D (kindly provided by
Tony DeMaggio, ICOS Corp., Bothell, Wash.)
at 0.28 mg/ml. A monoclonal
anti-Rad50 antibody (Novus) was used
at a dilution of 1:500 to detect
Rad50. Biotinylated antibody
9E10 to the Myc epitope tag was used
to detect NbFR5 and NbFR5-1
constructs tagged with a Myc epitope.
Membranes were probed with
primary antibody for 1 h at room
temperature. After washing, the
blots were probed with horseradish
peroxidase-conjugated goat
anti-mouse IgG or goat anti-rabbit IgG
(Pharmingen, San Diego,
Calif.) at a dilution of 1:4,000 for 1 h
at room temperature.
Bitotinylated anti-Myc antibody was detected with
streptavidin-horseradish
peroxidase conjugate (Amersham Pharmacia
Biotech) at a dilution
of 1:1,000. Blots were washed and developed
using the Amersham
enhanced chemiluminescence
system.
Immunofluorescence staining.
Immunofluorescence staining was
performed as described elsewhere (30), with a few
modifications. Fibroblast cell lines were plated at 1 × 105 to 2 × 105 cells per coverslip in
glass vials (Viromed Laboratories Inc., Minneapolis, Minn.) and grown
for 24 h. The cells were irradiated with 12 Gy from a Mark 1 model
22 cesium source (J. L. Shepherd and Associates, San Fernando,
Calif.). The medium was replaced; cells were incubated for an
additional 8 h and then fixed and permeabilized in 4%
formaldehyde with 0.1% Triton-X 100 for 10 min. After being washed
with phosphate-buffered saline (PBS) twice for 5 min each time,
coverslips were blocked in PBS with 10% FCS and incubated at 4°C
overnight. Cells were washed and incubated with polyclonal nibrin
antibody (Novus) at 1:2,000 dilution and monoclonal Mre11 antibody at
0.7 mg/ml for 1 h at room temperature. After being washed four
times with PBS, cells were incubated with goat anti-rabbit IgG
conjugated to Alexa 568 (Molecular Probes Inc., Eugene, Oreg.) and goat
anti-mouse IgG conjugated to Alexa 488 (Molecular Probes), both at
1:150 dilution, for 1 h at room temperature. Coverslips were
washed four times with PBS, and nuclei were counterstained with TOTO-3
iodide (Molecular Probes) at 1 µM for 40 min. After a final wash with
PBS, cells were mounted in Vectashield mounting medium (Vector
Laboratories Inc., Burlingame, Calif.). Immunofluorescence was analyzed
using a Nikon fluorescence microscope and a Bio-Rad confocal imaging
system at 488, 568, and 647 nm (TOTO-3 staining). For visualizing foci,
individual cells were z planed (18 to 20 sections), and images of
individual sections were stacked to produce a final image of the cell.
The percentage of cells with nuclear foci was determined by counting a
minimum of 100 cells using a 100× oil immersion lens of the Nikon
fluorescence microscope.
Colony survival assay.
Cells were exposed to 0, 1, 2, or 3 Gy of ionizing radiation from a J. L. Shepherd Mark I model 22 cesium source and plated at 600 cells per 100-mm-diameter tissue
culture dish in quadruplicate for each condition. After 10 days at
37°C, tissue culture dishes were washed once with PBS, stained with
1× Coomasie blue stain (Bio-Rad) for 5 min, and washed a final time
with PBS. Colonies per plate were enumerated, and the mean ± standard deviation was determined at each dose of radiation. The
survival fraction was calculated as the percentage of the unirradiated
control. Results were graphed using GraphPad Prism version 3.00 for Windows (GraphPad Software, San Diego, Calif.). All cell lines were
tested in two or more independent experiments.
 |
RESULTS |
The carboxy-terminal end of nibrin interacts with the
amino-terminal region of Mre11 in vitro.
To map regions of
nibrin that could potentially interact with Mre11, the full-length
NBS1 gene and a series of five subfragments (NbFR1 to -5)
overlapping by approximately 300 bp were cloned into plasmid pAS2-1.
Yeast strain Y190 was separately cotransformed with a full-length copy
of MRE11 cloned into the pACT2 plasmid and each of the
individual subclones of NBS1. To assess interaction between
nibrin and Mre11, colonies arising from each cotransformation were
tested for histidine prototrophy and assayed for
-galactosidase production in a filter assay.
-Gal activity was further quantitated in an o-nitrophenyl-
-D-galactopyranoside
assay to provide a relative measure of the strength of interactions
between various fragments. There was a strong interaction between
full-length nibrin and Mre11 in the yeast two-hybrid analyses as
expected (Fig. 1). Of the subfragments of
nibrin, only NbFR5, containing the C-terminal 354 amino acids,
displayed any significant evidence of interaction with full-length
Mre11. Since NbFR4 failed to interact with Mre11, the region of NbFR5
that did not overlap with NbFR4 (aa 653 to 754) and three overlapping
subfragments of this region were cloned in pAS2-1 and tested
for interaction with Mre11. The C-terminal 101-aa fragment of
nibrin, NbFR5-1, interacted strongly with Mre11 (Fig. 1). A
reciprocal fragment, Nb652, containing aa 1 to 652 of nibrin displayed
no evidence of interaction with Mre11. There was a variable response
from the three overlapping subfragments of NbFR5-1, NbFR5a being the
strongest, NbFR5b being slightly but not significantly weaker, and
NbFR5c showing a significant reduction in
-Gal activity.

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 1.
Interaction of nibrin subfragments with full-length
Mre11 in the yeast two-hybrid system. Full-length nibrin and
subfragments as indicated in the diagram were expressed as fusion
proteins in pAS2-1 and individually tested for interaction with
full-length Mre11 expressed in pACT2. Numbers flanking individual
fragments indicate amino acid positions. -Gal activity was measured
by liquid assay as described in Materials and Methods. For each
combination, three or more independent colonies were tested in
duplicate for -Gal production. The results are normalized to the
-Gal activity of the pAS2-1 vector alone. Growth was assessed by
observing the viability of cotransformants on SD medium lacking uracil,
lysine, tryptophan, leucine, and histidine and supplemented with 30 mM
3-amino-1,2,4-triazole.
|
|
To map the corresponding regions of Mre11 that interact with nibrin,
yeast strain Y190 was individually cotransformed with
a full-length
clone of NBS1 in pAS2-1 and each of five overlapping
fragments of Mre11
(MrFR1 to

5) cloned in pACT2. MrFR1 (aa 1
to 319) displayed a
significant interaction with full-length nibrin
comparable to that
observed for full-length Mre11 (Fig.
2).
However,
it was not possible to further subdivide this fragment and
maintain
interaction (e.g., fragment MrFR1-1, MrFR1-3, MrFR1-5, or
MrFR1-6).

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 2.
Interaction of Mre11 subfragments with full-length
nibrin in the yeast two-hybrid system. MRE11 subfragments cloned in
pACT2 were tested for interaction with full-length nibrin cloned in
pAS2-1. Numbers flanking individual fragments indicate amino acid
positions. -Gal production and growth on selective media were
determined as for Fig. 1.
|
|
Two-hybrid analysis using full-length interacting partners indicated
that aa 653 to 754 of nibrin and 1 to 319 of Mre11 were
necessary
for interaction. To determine if these regions of nibrin
and Mre11 were
sufficient to mediate interaction by themselves,
subfragments
NbFR5-1 (aa 653 to 754) and MrFR1 (aa 1 to 319) were
cotransformed into
yeast. As expected, the two subfragments interacted
with each other
(>100-fold excess

-Gal production over vector
alone).
Since the stoichiometry of nibrin-Mre11-Rad50 complexes is not known,
nibrin and Mre11 were also tested for possible homodimerization
in the
yeast two-hybrid system. No interaction between full-length
copies of
nibrin cloned in pAS2-1 and pACT2 was observed. In contrast,
interaction between full-length Mre11 molecules in pAS2-1 and
pACT2 was
observed, indicating that human Mre11 can potentially
homodimerize
(data not
shown).
The carboxy-terminal region of nibrin interacts with Mre11 in
vivo.
To evaluate whether the C-terminal region of nibrin
identified in the yeast two-hybrid screen could interact with Mre11 in vivo, Nb652, NbFR5, and NbFR5-1 were separately cloned in the retroviral expression vector pLXIN. Because NbFR5 and NbFR5-1 were short fragments that might not be detected with
antibodies to nibrin, these constructs were tagged with a Myc
epitope. Viral supernatants were prepared and used to infect an
SV40-transformed fibroblast line from an NBS patient homozygous for the
predominant 657del5 mutation that produces no detectable endogenous
nibrin protein (NBS-ILB1). For comparison, the full-length
NBS1 gene was expressed using the same retroviral vector
system. Immunoprecipitation with an antinibrin antibody coprecipitated
comparable amounts of the 85-kDa Mre11 protein from a control
fibroblast line, GM637, and from NBS1-infected NBS-ILB1 cells but not
from cells infected with vector alone (Fig.
3). Cell lysates from NbFR5 and
NbFR5-1-infected cells were immunoprecipitated with an
antibody to the Myc tag (Fig. 3). NbFR5 was able to interact with and
immunoprecipitate the Mre11 protein in the retrovirus-infected NBS-ILB1
cells; however, NbFR5-1 immunoprecipitated significantly less Mre11
(Fig. 3A). Probing with an antibody to the Myc epitope tag revealed
the expected 50-kDa band for NbFR5 but not the expected 18-kDa band for
NbFR5-1 (Fig. 3B). Similar results were obtained in transient
transfections with NbFR5-1, suggesting that this fragment is unstable
or rapidly turned over (data not shown).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Interaction of NbFR5 and NbFR5-1 with Mre11 by
immunoprecipitation and Western blot analysis. (A) Total cell lysates
were prepared from normal control cell line GM637 and the NBS-ILB1 cell
line separately infected with retrovirus carrying the pLXIN vector
alone (LXIN), the NBS1 gene (NBS1), the NbFR5 fragment
(NbFR5), or the NbFR5-1 fragment (NbFR5-1). Cell lysates were
immunoprecipitated (IP) with an antibody directed against nibrin ( Nibrin) or the Myc epitope tag ( myc) and fractionated on a
discontinuous polyacrylamide gel. After electrophoretic transfer to a
membrane, the blot was probed with a monoclonal antibody to Mre11. The
migration of molecular weight markers is indicated on the left (in
kilodaltons). (B) Cell lysates from panel A that were
immunoprecipitated with an antibody directed against the Myc
epitope tag were fractionated on a protein gel and probed with
biotinylated anti-Myc antibody.
|
|
Cell lysates from NBS1 and Nb652 virus-infected cells were
immunoprecipitated with an antinibrin antibody, and proteins were
detected by Western blot analysis using antibodies against nibrin,
Mre11, and Rad50 (Fig.
4).
Immunoprecipitation of nibrin from
NBS1-infected cells coprecipitated
Mre11 and Rad50 in amounts
comparable to or greater than that observed
in MRC5 cells. In
contrast, cells infected with the Nb652 virus
produced substantial
amounts of the truncated 79-kDa form of nibrin,
but antibodies
to nibrin did not coprecipitate Mre11 or Rad50 protein
above the
background level observed in cells infected with pLXIN vector
alone.

View larger version (50K):
[in this window]
[in a new window]
|
FIG. 4.
Interaction of the Nb652 mutant with Mre11 and Rad50 by
immunoprecipitation and Western blot analysis. Total cell lysates were
prepared from a normal control cell line (MRC5) and NBS-ILB1 cells
separately infected with the pLXIN vector alone (LXIN), with the NBS1
retrovirus (NBS1), or with the Nb652 retrovirus (Nb652). Lysates were
immunoprecipitated (IP) with control rabbit IgG ( ) or polyclonal
nibrin antiserum ( Nibrin; +). After Western transfer, the blot was
probed with the antinibrin antiserum, an Mre11 monoclonal antibody, and
a monoclonal anti-Rad50 antibody. The migration of molecular weight
markers is indicated on the left (in kilodaltons).
|
|
Mre11 binding is not necessary for nuclear focus formation by
nibrin.
To determine if direct interaction between nibrin and
Mre11 is sufficient for nuclear localization of Mre11 and Rad50, as well as for IRIF formation, we assayed the effect of expression of
NbFR5 and Nb652 on these phenotypes by staining with antibodies to
nibrin and Mre11. In the NBS-ILB1 cell line infected with the NBS1,
NbFR5, or Nb652 retrovirus, nibrin expression was exclusively nuclear
(Fig. 5A). The NBS1 and NbFR5 constructs,
which retain the Mre11 interaction site, were able to relocalize Mre11
to the nucleus, as indicated by the yellow staining in the merged
image. In contrast, the Nb652 construct, which lacked the Mre11 binding site, localized to the nucleus, while Mre11 remained in the cytoplasm.

View larger version (81K):
[in this window]
[in a new window]
|
FIG. 5.
Subcellular localization of nibrin and Mre11 detected by
immunofluorescence. Cells plated on coverslips were either untreated or
exposed to 12 Gy of ionizing radiation. After 8 h, the cells were
fixed and stained with antinibrin antiserum (red) and anti-Mre11
monoclonal (green). Merged panels represent overlapped images of nibrin
and Mre11 staining results. (A) Localization of nibrin and Mre11 in
unirradiated NBS-ILB1 cells expressing vector alone (LXIN), full-length
nibrin (NBS1), nibrin fragment 5 (NbFR5), or the truncated 79-kDa form
(Nb652). (B) Localization of nibrin and Mre11 in NBS-ILB1 cells
expressing full-length nibrin (NBS1), nibrin fragment 5 (NbFR5), or the
truncated 79-kDa form (Nb652) after irradiation. Cells were
counterstained with the nuclear dye TOTO-3 (blue).
|
|
Upon irradiation, the NBS1-infected cell line displayed increased
numbers of nuclear foci containing both nibrin and Mre11
(Fig.
5B), as
observed in normal cell lines (
4,
5,
13,
18). The
Nb652-infected NBS-ILB1 cells were able to form nuclear
foci containing
nibrin, but these foci lacked Mre11, as evidenced
by the nonoverlapping
staining patterns for nibrin and Mre11 in
the merged image (Fig.
5B).
These nibrin foci were qualitatively
similar to those formed in normal
cells by the complex of all
three proteins, nibrin, Mre11, and Rad50,
and were radiation inducible.
Interestingly, the NbFR5 construct,
though able to relocalize
Mre11 to the nucleus, formed no nuclear foci
detectable with antibodies
to either nibrin or Mre11 in either
irradiated or unirradiated
cells (Fig.
5).
The number of cells displaying nuclear foci and the number of foci per
cell were quantitated pre- and postirradiation in cells
infected with
the NBS1, NbFR5, or Nb652 retrovirus (Table
1).
NBS-ILB1 cells infected with the NBS1
or Nb652 retrovirus were
indistinguishable in terms of number of cells
with foci and number
of foci per cell whether irradiated or
unirradiated. In contrast,
no foci were detected in NBS-ILB1 cells
infected with the NbFR5
virus.
Radiation sensitivity of NBS cells expressing NbFR5 or Nb652.
Cells from NBS patients display hypersensitivity to ionizing radiation
that can be fully complemented by the introduction of a functional copy
of the NBS1 gene (5, 13). To evaluate the role
of Mre11-nibrin interaction in radiation sensitivity, we irradiated NBS
fibroblasts expressing Nb652 or NbFR5 with increasing doses of X rays
and determined their survival relative to normal control cells (MRC5),
NBS1-infected cells, and cells infected with empty vector (LXIN) in a
standard colony-forming assay. Neither Nb652 nor NbFR5 could fully
complement the radiation hypersensitivity of NBS-ILB1 cells to levels
observed with NBS1 or normal controls (Fig.
6). However, in multiple assays we
consistently observed that NBS cells expressing NbFR5 were less
radiation sensitive than cells expressing Nb652 or pLXIN at all doses
tested.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 6.
Radiation sensitivity of NBS-ILB1 cells expressing
different nibrin constructs. A normal control cell line (MRC5) and
NBS-ILB1 cell line infected with the pLXIN vector (LXIN), NBS1, NbFR5,
or Nb652 retrovirus were exposed to 0, 1, 2, or 3 Gy of ionizing
radiation. After 10 days, colonies per plate were counted and expressed
as the percentage of the unirradiated control. Each data point
represents the mean and standard deviation of quadruplicate values.
|
|
 |
DISCUSSION |
In normal fibroblasts, nibrin is distributed relatively
homogeneously in the nucleus in association with the proteins Mre11 and
Rad50 (4). Upon irradiation of fibroblasts, this
multiprotein complex redistributes, resulting in a high percentage of
cells displaying distinct nuclear foci detectable with antibodies to any of the three components of the complex. Other proteins, including BRCA1 and ATM, are likely to be transiently associated with this complex, possibly in a cell type or cell cycle-specific manner (10, 17, 28, 29). In NBS cells, where nibrin is absent, the Mre11 and Rad50 proteins complex with each other but remain cytoplasmic. Based on this phenotype of NBS cells, nibrin was assumed
to be necessary for the nuclear localization of Mre11 and Rad50
(4). What the role of nibrin is in the formation of
nuclear foci and whether direct or indirect interactions with Mre11 or
Rad50 are required for either nuclear localization or focus formation
are unclear. In this study, we have mapped the corresponding
interaction sites on both nibrin and Mre11 and examined the role of
direct nibrin-Mre11 interaction in nuclear localization, focus
formation after irradiation, and radiation sensitivity by mutagenesis
and expression of nibrin constructs.
Mre11 and nibrin interact strongly in a yeast two-hybrid screen,
consistent with the ease with which they can be coimmunoprecipitated from human fibroblasts. Fine mapping of the interaction domains revealed that the C-terminal 101 aa of nibrin were sufficient for this
interaction. Two of three subfragments of this 101-aa region displayed
some degree of interaction, suggesting that nibrin-Mre11 binding occurs
over a broad surface, the primary sequence of which is highly conserved
between the mouse and human proteins (27).
Localization of the site of nibrin interaction on Mre11 was more
difficult. Yeast two-hybrid screening of fragments of Mre11 localized
this site to the amino-terminal 319 aa. However, none of a panel of
subfragments from this region revealed any evidence of interaction with
nibrin when expressed individually. This N-terminal localization is
consistent with a report that a mutation of N to S at position 117 in
Mre11, found in two families with an ataxia-telangiectasia-like disorder (ATLD), weakens the interaction between Mre11 and nibrin as
assayed by coimmunoprecipitation (23). There are several possible explanations for the difficulty in defining a smaller interaction domain on Mre11 by truncation. The bacterial homologue of
Mre11, SbcD, binds Mn2+, and this binding has
substantial global effects on the structure of SbcD (8).
If the N-terminal region of Mre11 is similarly involved in binding
metal ions, then disruption of this binding may have broad effects on
the structure of Mre11. Mutational analyses also indicate that Rad50
binding is dependent on several distinct sites in this region of Mre11
(3). Binding of Rad50 may be required for stabilization of
Mre11 structure and/or to facilitate nibrin binding.
Yeast two-hybrid analyses also suggested the potential for
homodimerization of Mre11 but not nibrin. These results are of interest
in terms of defining the stoichiometry of the complex formed by nibrin,
Mre11, and Rad50 but should be considered with caution since they could
reflect the detection of intramolecular rather than intermolecular
interaction sites. Similar results have been described for Mre11 in
S. cerevisiae (7, 15).
In this study, a deletion mutant of nibrin lacking the Mre11
interaction domain was constructed and introduced into NBS cells. This
mutant form of nibrin, Nb652, failed to interact with Mre11 in vivo and
did not restore the nuclear localization of either Mre11 or Rad50.
Nb652 did form nuclear foci that, although lacking Mre11 and Rad50,
were normal in morphology, frequency, and response to ionizing
radiation. However, this ability to form nibrin foci did not result in
any significant complementation of the radiation-sensitive phenotype of
these cells. These results indicate that nibrin is capable of directing
its own nuclear localization and focus formation independent of its
interaction with Mre11.
Interestingly, the phenotype of cells expressing Nb652 is distinct from
that of cells from ATLD patients with the Mre11 N117S mutation
(23). The Mre11 N117S mutation is proposed to weaken the
interaction between nibrin and Mre11, based on the reduced amount of
nibrin that could be coimmunoprecipitated from patient cell lines with
antibodies to Mre11. Neither nibrin nor Mre11 display their
characteristic nuclear localization in these cells. A major difference
between cells expressing the Nb652 form of nibrin and those expressing
the N117S form of Mre11 is that the nibrin truncation completely
eliminates interaction between nibrin and Mre11, while the Mre11 N117S
mutation retains the interaction but weakens or alters it in some way.
The contrasting phenotypes of these mutations with regard to nibrin
localization and focus formation suggest that the N117S form of Mre11
may exert some negative effect on nibrin in ATLD cells. For example,
the N117S mutated Mre11 might bind to nibrin in an altered conformation that would block access to a nuclear localization signal or to an
interaction site for a third protein necessary for transposition to, or
retention within, the nucleus.
Both the NbFR5 and Nb652 expression constructs used in this study
localized to the nucleus despite deletions that eliminated potential
protein-protein interaction sites at the N- and C-terminal ends of the
protein. This suggests that residues in the overlapping region between
these constructs are sufficient to mediate nuclear localization of
nibrin. Within this region, residues 401 to 652, there are two
potential nuclear localization signals, both of which are conserved in
the mouse homologue of nibrin and one of which is also conserved in the
Drosophila homologue.
Are there distinct functions related to DNA repair or cell survival
that are attributable to nibrin, or does it simply act as a molecular
chaperone, delivering Mre11 and Rad50 to the nucleus? All reported
mutations in NBS patients are predicted to prematurely terminate the
nibrin protein, and full-length nibrin is not detected in cell lines
from these patients by Western blotting (4). These
mutations provide no information that might help to partition the
cellular phenotypes associated with NBS into those that might be
specific to nibrin and others that might be dependent on its interaction with Mre11. In this study, expression of NbFR5 in NBS-ILB1
cells restored the interaction between nibrin and Mre11, allowing
nuclear localization of these proteins but not the formation of nuclear
foci. These results indicate that sequences in the amino-terminal half
of nibrin are required for focus formation. Expression of NbFR5 also
failed to fully complement the radiation sensitivity phenotype of NBS
cells. The level of radiation sensitivity in NBS cells expressing NbFR5
is comparable to that observed when the same retroviral system was used
to express an altered form of nibrin, S343A, in which serine 343, a
target of the ATM kinase, had been changed to alanine by site-specific
mutagenesis (10). NbFR5 lacks this phosphorylation site,
which may explain in part its lack of full complementation. The S343A
mutant restores focus formation whereas NbFR5 does not, indicating a
requirement for sequences other than just S343 in the amino-terminal
half of nibrin for this function.
In summary, direct physical interaction with Mre11 is required for
normal cellular survival after radiation exposure but is dispensable
for correct nuclear localization and for formation of IRIF by nibrin.
Our results define several distinct functional domains within nibrin.
Translocation of Mre11 and Rad50 to the nucleus is necessary but not
sufficient for focus formation, which is dependent on residues in the
amino-terminal half of nibrin. The N-terminal FHA and BRCT domains of
nibrin are obvious candidates for this function. Sequences between
amino acid residues 401 and 652 of nibrin are sufficient to direct its
nuclear localization independent of its interaction with Mre11.
Finally, the C-terminal 101 aa of nibrin are necessary for Mre11
binding and for cellular survival after radiation exposure. However,
full complementation of radiation sensitivity in NBS cells requires
additional amino-terminal sequences of nibrin and/or phosphorylation on
multiple serine residues.
 |
ACKNOWLEDGMENTS |
This work was supported by grant CA57569 from the National Cancer
Institute to P.C. and by an A-T Medical Research Foundation fellowship
to A.D.-M.
We thank Tony DeMaggio for the kind gift of the Mre11 monoclonal
antibody, Malgorzata Zdzienicka for the NBS-ILB1 fibroblast cell line,
Tiong Chia Yeo for isolating the full-length NBS1 cDNA, and Lindsey
Johnson for nucleotide sequencing.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Molecular
Genetics Program, Virginia Mason Research Center, 1201 Ninth Ave.,
Seattle, WA 98101-2795. Phone: (206) 223-6476. Fax: (206)
625-7213. E-mail: patcon{at}u.washington.edu.
 |
REFERENCES |
| 1.
|
Bartel, P. L., and S. Fields.
1995.
Analyzing protein-protein interactions using two-hybrid system.
Methods Enzymol.
254:241-263[Medline].
|
| 2.
|
Bork, P.,
K. Hofmann,
P. Bucher,
A. F. Neuwald,
S. F. Altschul, and E. V. Koonin.
1997.
A superfamily of conserved domains in DNA damage-responsive cell cycle checkpoint proteins.
FASEB J.
11:68-76[Abstract].
|
| 3.
|
Bressan, D. A.,
H. A. Olivares,
B. E. Nelms, and J. H. Petrini.
1998.
Alteration of N-terminal phosphoesterase signature motifs inactivates Saccharomyces cerevisiae Mre11.
Genetics
150:591-600[Abstract/Free Full Text].
|
| 4.
|
Carney, J. P.,
R. S. Maser,
H. Olivares,
E. M. Davis,
M. Le Beau,
J. R. Yates III,
L. Hays,
W. F. Morgan, and J. H. Petrini.
1998.
The hMre11/hRad50 protein complex and Nijmegen breakage syndrome: linkage of double-strand break repair to the cellular DNA damage response.
Cell
93:477-486[CrossRef][Medline].
|
| 5.
|
Cerosaletti, K. M.,
A. Desai-Mehta,
T. C. Yeo,
M. Kraakman-van der Zwet,
M. Z. Zdzienicka, and P. Concannon.
2000.
Retroviral expression of the NBS1 gene in cultured Nijmegen breakage syndrome cells restores normal radiation sensitivity and nuclear focus formation.
Mutagenesis
15:281-286[Abstract/Free Full Text].
|
| 6.
|
Cerosaletti, K. M.,
E. Lange,
H. M. Stringham,
C. M. Weemaes,
D. Smeets,
B. Solder,
B. H. Belohradsky,
A. M. Taylor,
P. Karnes,
A. Elliott,
K. Komatsu,
R. A. Gatti,
M. Boehnke, and P. Concannon.
1998.
Fine localization of the Nijmegen breakage syndrome gene to 8q21: evidence for a common founder haplotype.
Am. J. Hum. Genet.
63:125-134[CrossRef][Medline].
|
| 7.
|
Chamankhah, M., and W. Xiao.
1999.
Formation of the yeast Mre11-Rad50-Xrs2 complex is correlated with DNA repair and telomere maintenance.
Nucleic Acids Res.
27:2072-2079[Abstract/Free Full Text].
|
| 8.
|
Connelly, J. C.,
E. S. de Leau,
E. A. Okely, and D. R. Leach.
1997.
Overexpression, purification, and characterization of the SbcCD protein from Escherichia coli.
J. Biol. Chem.
272:19819-19826[Abstract/Free Full Text].
|
| 9.
|
Evan, G. I.,
G. K. Lewis,
G. Ramsay, and J. M. Bishop.
1985.
Isolation of monoclonal antibodies specific for human c-myc proto-oncogene product.
Mol. Cell. Biol.
5:3610-3616[Abstract/Free Full Text].
|
| 10.
|
Gatei, M.,
D. Young,
K. M. Cerosaletti,
A. Desai-Mehta,
K. Spring,
S. Kozlov,
M. F. Lavin,
R. A. Gatti,
P. Concannon, and K. Khanna.
2000.
ATM-dependent phosphorylation of nibrin in response to radiation exposure.
Nat. Genet.
25:115-119[CrossRef][Medline].
|
| 11.
|
Hofmann, K, and P. Bucher.
1995.
The FHA domain: a putative nuclear signalling domain found in protein kinases and transcription factors.
Trends Biochem. Sci.
20:347-349[CrossRef][Medline].
|
| 12.
|
Huschtscha, L. I., and R. Holliday.
1983.
Limited and unlimited growth of SV40-transformed cells from human diploid MRC-5 fibroblasts.
J. Cell Sci.
63:77-99[Abstract].
|
| 13.
|
Ito, A.,
H. Tauchi,
J. Kobayashi,
K. Morishima,
A. Nakamura,
Y. Hirokawa,
S. Matsuura,
K. Ito, and K. Komatsu.
1999.
Expression of full-length NBS1 protein restores normal radiation responses in cells from Nijmegen breakage syndrome patients.
Biochem. Biophys. Res. Commun.
265:716-721[CrossRef][Medline].
|
| 14.
|
Jaspers, N. G.,
R. D. Taalman, and C. Baan.
1988.
Patients with an inherited syndrome characterized by immunodeficiency, microcephaly, and chromosomal instability: genetic relationship to ataxia telangiectasia.
Am. J. Hum. Genet.
42:66-73[Medline].
|
| 15.
|
Johzuka, K., and H. Ogawa.
1995.
Interaction of Mre11 and Rad50: two proteins required for DNA repair and meiosis-specific double-strand break formation in Saccharomyces cerevisiae.
Genetics
139:1521-1532[Abstract].
|
| 16.
|
Kraakman-van der Zwet, M.,
W. J. Overkamp,
A. A. Friedl,
B. Klein,
G. W. Verhaegh,
N. G. Jaspers,
A. T. Midro,
F. Eckardt-Schupp,
P. H. Lohman, and M. Z. Zdzienicka.
1999.
Immortalization and characterization of Nijmegen breakage syndrome fibroblasts.
Mutat. Res.
434:17-27[Medline].
|
| 17.
|
Lim, D. S.,
S. T. Kim,
B. Xu,
R. S. Maser,
J. Lin,
J. H. Petrini, and M. B. Kastan.
2000.
ATM phosphorylates p95/nbs1 in an S-phase checkpoint pathway.
Nature
404:613-617[CrossRef][Medline].
|
| 18.
|
Maser, R. S.,
K. J. Monsen,
B. E. Nelms, and J. H. Petrini.
1997.
hMre11 and hRad50 nuclear foci are induced during the normal cellular response to DNA double-strand breaks.
Mol. Cell. Biol.
17:6087-6096[Abstract].
|
| 19.
|
Matsuura, S.,
H. Tauchi,
A. Nakamura,
N. Kondo,
S. Sakamoto,
S. Endo,
D. Smeets,
B. Solder,
B. H. Belohradsky,
K. Der,
V. M. Oshimura,
M. Isomura,
Y. Nakamura, and K. Komatsu.
1998.
Positional cloning of the gene for Nijmegen breakage syndrome.
Nat. Genet.
19:179-181[CrossRef][Medline].
|
| 20.
|
Matsuura, S.,
C. Weemaes,
D. Smeets,
H. Takami,
N. Kondo,
S. Sakamoto,
N. Yano,
A. Nakamura,
H. Tauchi,
S. Endo,
M. Oshimura, and K. Komatsu.
1997.
Genetic mapping using microcell-medicated chromosome transfer suggests a locus for Nijmegen breakage syndrome at chromosome 8q21-24.
Am. J. Hum. Genet.
60:1487-1494[Medline].
|
| 21.
|
Nelms, B. E.,
R. S. Maser,
J. F. MacKay,
M. G. Lagally, and J. H. Petrini.
1998.
In situ visualization of DNA double-strand break repair in human fibroblasts.
Science
280:590-592[Abstract/Free Full Text].
|
| 22.
|
Saar, K.,
K. H. Chrzanowska,
M. Stumm,
M. Jung,
G. Nurnberg,
T. F. Wienker,
E. Seemanova,
R. D. Wegner,
A. Reis, and K. Sperling.
1997.
The gene for the ataxia-telangiectasia variant, Nijmegen breakage syndrome, maps to a 1-cM interval on chromosome 8q21.
Am. J. Hum. Genet.
60:605-610[Medline].
|
| 23.
|
Stewart, G. S.,
R. S. Maser,
T. Stankovic,
D. A. Bressan,
M. I. Kaplan,
N. G. Jaspers,
A. Raams,
P. J. Byrd,
J. H. Petrini, and A. M. Taylor.
1999.
The DNA double-strand break repair gene hMRE11 is mutated in individuals with an ataxia-telangiectasia-like disorder.
Cell
99:577-587[CrossRef][Medline].
|
| 24.
|
Taalman, R. D.,
T. W. Hustinx,
C. M. Weemaes,
E. Seemanova,
A. Schmidt,
E. Passarge, and J. M. Scheres.
1989.
Further delineation of the Nijmegen breakage syndrome.
Am. J. Med. Genet.
32:425-431[CrossRef][Medline].
|
| 25.
|
van der Burgt, I.,
K. H. Chrzanowska,
D. Smeets, and C. Weemaes.
1996.
Nijmegen breakage syndrome.
J. Med. Genet.
33:153-156[Abstract/Free Full Text].
|
| 26.
|
Varon, R.,
C. Vissinga,
M. Platzer,
K. M. Cerosaletti,
K. H. Chrzanowska,
K. Saar,
G. Beckmann,
E. Seemanova,
P. R. Cooper,
N. J. Nowak,
M. Stumm,
C. M. Weemaes,
R. A. Gatti,
R. K. Wilson,
M. Digweed,
A. Rosenthal,
K. Sperling,
P. Concannon, and A. Reis.
1998.
Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome.
Cell
93:467-476[CrossRef][Medline].
|
| 27.
|
Vissinga, C. S.,
T. C. Yeo,
J. Woessner,
H. F. Massa,
R. K. Wilson,
B. J. Trask, and P. Concannon.
1999.
Identification, characterization, and mapping of a mouse homolog of the gene mutated in Nijmegen breakage syndrome.
Cytogenet. Cell Genet.
87:80-84[CrossRef][Medline].
|
| 28.
|
Wang, Y.,
D. Cortez,
P. Yazdi,
N. Neff,
S. J. Elledge, and J. Qin.
2000.
BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures.
Genes Dev.
14:927-939[Abstract/Free Full Text].
|
| 29.
|
Zhong, Q.,
C. F. Chen,
S. Li,
Y. Chen,
C. C. Wang,
J. Xiao,
P. L. Chen,
Z. D. Sharp, and W. H. Lee.
1999.
Association of BRCA1 with the hRad50-hMre11-p95 complex and the DNA damage response.
Science
285:747-750[Abstract/Free Full Text].
|
| 30.
|
Ziv, Y.,
A. Bar-Shira,
I. Pecker,
P. Russell,
T. J. Jorgensen,
I. Tsarfati, and Y. Shiloh.
1997.
Recombinant ATM protein complements the cellular A-T phenotype.
Oncogene
15:159-167[CrossRef][Medline].
|
Molecular and Cellular Biology, March 2001, p. 2184-2191, Vol. 21, No. 6
0270-7306/01/$04.00+0 DOI: 10.1128/MCB.21.6.2184-2191.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Gao, G., Bi, X., Chen, J., Srikanta, D., Rong, Y. S.
(2009). Mre11-Rad50-Nbs complex is required to cap telomeres during Drosophila embryogenesis. Proc. Natl. Acad. Sci. USA
106: 10728-10733
[Abstract]
[Full Text]
-
Karen, K. A., Hoey, P. J., Young, C. S. H., Hearing, P.
(2009). Temporal Regulation of the Mre11-Rad50-Nbs1 Complex during Adenovirus Infection. J. Virol.
83: 4565-4573
[Abstract]
[Full Text]
-
Vissinga, C. S., Yeo, T. C., Warren, S., Brawley, J. V., Phillips, J., Cerosaletti, K., Concannon, P.
(2009). Nuclear Export of NBN Is Required for Normal Cellular Responses to Radiation. Mol. Cell. Biol.
29: 1000-1006
[Abstract]
[Full Text]
-
Stiff, T., Cerosaletti, K., Concannon, P., O'Driscoll, M., Jeggo, P. A.
(2008). Replication independent ATR signalling leads to G2/M arrest requiring Nbs1, 53BP1 and MDC1. Hum Mol Genet
17: 3247-3253
[Abstract]
[Full Text]
-
Margulis, V., Lin, J., Yang, H., Wang, W., Wood, C. G., Wu, X.
(2008). Genetic Susceptibility to Renal Cell Carcinoma: The Role of DNA Double-Strand Break Repair Pathway. Cancer Epidemiol. Biomarkers Prev.
17: 2366-2373
[Abstract]
[Full Text]
-
Lakdawala, S. S., Schwartz, R. A., Ferenchak, K., Carson, C. T., McSharry, B. P., Wilkinson, G. W., Weitzman, M. D.
(2008). Differential Requirements of the C Terminus of Nbs1 in Suppressing Adenovirus DNA Replication and Promoting Concatemer Formation. J. Virol.
82: 8362-8372
[Abstract]
[Full Text]
-
Riches, L. C., Lynch, A. M., Gooderham, N. J.
(2008). Early events in the mammalian response to DNA double-strand breaks. Mutagenesis
23: 331-339
[Abstract]
[Full Text]
-
Wen, Q., Scorah, J., Phear, G., Rodgers, G., Rodgers, S., Meuth, M.
(2008). A Mutant Allele of MRE11 Found in Mismatch Repair-deficient Tumor Cells Suppresses the Cellular Response to DNA Replication Fork Stress in a Dominant Negative Manner. Mol. Biol. Cell
19: 1693-1705
[Abstract]
[Full Text]
-
Schild-Poulter, C., Su, A., Shih, A., Kelly, O. P., Fritzler, M. J., Goldstein, R., Hache, R. J. G.
(2008). Association of autoantibodies with Ku and DNA repair proteins in connective tissue diseases. Rheumatology (Oxford)
47: 165-171
[Abstract]
[Full Text]
-
Dote, H., Burgan, W. E., Camphausen, K., Tofilon, P. J.
(2006). Inhibition of hsp90 compromises the DNA damage response to radiation.. Cancer Res.
66: 9211-9220
[Abstract]
[Full Text]
-
Becker, E., Meyer, V., Madaoui, H., Guerois, R.
(2006). Detection of a tandem BRCT in Nbs1 and Xrs2 with functional implications in the DNA damage response. Bioinformatics
22: 1289-1292
[Abstract]
[Full Text]
-
Cerosaletti, K., Wright, J., Concannon, P.
(2006). Active role for nibrin in the kinetics of atm activation.. Mol. Cell. Biol.
26: 1691-1699
[Abstract]
[Full Text]
-
Varon, R., Dutrannoy, V., Weikert, G., Tanzarella, C., Antoccia, A., Stockl, L., Spadoni, E., Kruger, L.-A., Masi, A. d., Sperling, K., Digweed, M., Maraschio, P.
(2006). Mild Nijmegen breakage syndrome phenotype due to alternative splicing. Hum Mol Genet
15: 679-689
[Abstract]
[Full Text]
-
Tseng, S.-F., Chang, C.-Y., Wu, K.-J., Teng, S.-C.
(2005). Importin KPNA2 Is Required for Proper Nuclear Localization and Multiple Functions of NBS1. J. Biol. Chem.
280: 39594-39600
[Abstract]
[Full Text]
-
Araujo, F. D., Stracker, T. H., Carson, C. T., Lee, D. V., Weitzman, M. D.
(2005). Adenovirus Type 5 E4orf3 Protein Targets the Mre11 Complex to Cytoplasmic Aggresomes. J. Virol.
79: 11382-11391
[Abstract]
[Full Text]
-
Shirata, N., Kudoh, A., Daikoku, T., Tatsumi, Y., Fujita, M., Kiyono, T., Sugaya, Y., Isomura, H., Ishizaki, K., Tsurumi, T.
(2005). Activation of Ataxia Telangiectasia-mutated DNA Damage Checkpoint Signal Transduction Elicited by Herpes Simplex Virus Infection. J. Biol. Chem.
280: 30336-30341
[Abstract]
[Full Text]
-
You, Z., Chahwan, C., Bailis, J., Hunter, T., Russell, P.
(2005). ATM Activation and Its Recruitment to Damaged DNA Require Binding to the C Terminus of Nbs1. Mol. Cell. Biol.
25: 5363-5379
[Abstract]
[Full Text]
-
Zhang, Y., Lim, C. U.K., Williams, E. S., Zhou, J., Zhang, Q., Fox, M. H., Bailey, S. M., Liber, H. L.
(2005). NBS1 Knockdown by Small Interfering RNA Increases Ionizing Radiation Mutagenesis and Telomere Association in Human Cells. Cancer Res.
65: 5544-5553
[Abstract]
[Full Text]
-
Alt, J. R., Bouska, A., Fernandez, M. R., Cerny, R. L., Xiao, H., Eischen, C. M.
(2005). Mdm2 Binds to Nbs1 at Sites of DNA Damage and Regulates Double Strand Break Repair. J. Biol. Chem.
280: 18771-18781
[Abstract]
[Full Text]
-
Shima, H., Suzuki, M., Shinohara, M.
(2005). Isolation and Characterization of Novel xrs2 Mutations in Saccharomyces cerevisiae. Genetics
170: 71-85
[Abstract]
[Full Text]
-
Tsukamoto, Y., Mitsuoka, C., Terasawa, M., Ogawa, H., Ogawa, T.
(2005). Xrs2p Regulates Mre11p Translocation to the Nucleus and Plays a Role in Telomere Elongation and Meiotic Recombination. Mol. Biol. Cell
16: 597-608
[Abstract]
[Full Text]
-
Fernet, M., Gribaa, M., Salih, M. A.M., Seidahmed, M. Z., Hall, J., Koenig, M.
(2005). Identification and functional consequences of a novel MRE11 mutation affecting 10 Saudi Arabian patients with the ataxia telangiectasia-like disorder. Hum Mol Genet
14: 307-318
[Abstract]
[Full Text]
-
Demuth, I., Frappart, P.-O., Hildebrand, G., Melchers, A., Lobitz, S., Stockl, L., Varon, R., Herceg, Z., Sperling, K., Wang, Z.-Q., Digweed, M.
(2004). An inducible null mutant murine model of Nijmegen breakage syndrome proves the essential function of NBS1 in chromosomal stability and cell viability. Hum Mol Genet
13: 2385-2397
[Abstract]
[Full Text]
-
Cerosaletti, K., Concannon, P.
(2004). Independent Roles for Nibrin and Mre11-Rad50 in the Activation and Function of Atm. J. Biol. Chem.
279: 38813-38819
[Abstract]
[Full Text]
-
Zhang, J., Willers, H., Feng, Z., Ghosh, J. C., Kim, S., Weaver, D. T., Chung, J. H., Powell, S. N., Xia, F.
(2004). Chk2 Phosphorylation of BRCA1 Regulates DNA Double-Strand Break Repair. Mol. Cell. Biol.
24: 708-718
[Abstract]
[Full Text]
-
Mochan, T. A., Venere, M., DiTullio, R. A. Jr., Halazonetis, T. D.
(2003). 53BP1 and NFBD1/MDC1-Nbs1 Function in Parallel Interacting Pathways Activating Ataxia-Telangiectasia Mutated (ATM) in Response to DNA Damage. Cancer Res.
63: 8586-8591
[Abstract]
[Full Text]
-
Heikkinen, K, Karppinen, S-M, Soini, Y, Makinen, M, Winqvist, R
(2003). Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility. J. Med. Genet.
40: e131-131
[Full Text]
-
Lee, J.-H., Ghirlando, R., Bhaskara, V., Hoffmeyer, M. R., Gu, J., Paull, T. T.
(2003). Regulation of Mre11/Rad50 by Nbs1: EFFECTS ON NUCLEOTIDE-DEPENDENT DNA BINDING AND ASSOCIATION WITH ATAXIA-TELANGIECTASIA-LIKE DISORDER MUTANT COMPLEXES. J. Biol. Chem.
278: 45171-45181
[Abstract]
[Full Text]
-
Ueno, M., Nakazaki, T., Akamatsu, Y., Watanabe, K., Tomita, K., Lindsay, H. D., Shinagawa, H., Iwasaki, H.
(2003). Molecular Characterization of the Schizosaccharomyces pombe nbs1+ Gene Involved in DNA Repair and Telomere Maintenance. Mol. Cell. Biol.
23: 6553-6563
[Abstract]
[Full Text]
-
Lee, J. H., Xu, B., Lee, C.-H., Ahn, J.-Y., Song, M. S., Lee, H., Canman, C. E., Lee, J.-S., Kastan, M. B., Lim, D.-S.
(2003). Distinct Functions of Nijmegen Breakage Syndrome in Ataxia Telangiectasia Mutated-Dependent Responses to DNA Damage. Mol Cancer Res
1: 674-681
[Abstract]
[Full Text]
-
Cerosaletti, K. M., Concannon, P.
(2003). Nibrin Forkhead-associated Domain and Breast Cancer C-terminal Domain Are Both Required for Nuclear Focus Formation and Phosphorylation. J. Biol. Chem.
278: 21944-21951
[Abstract]
[Full Text]
-
Chiang, Y.-C., Teng, S.-C., Su, Y.-N., Hsieh, F.-J., Wu, K.-J.
(2003). c-Myc Directly Regulates the Transcription of the NBS1 Gene Involved in DNA Double-strand Break Repair. J. Biol. Chem.
278: 19286-19291
[Abstract]
[Full Text]
-
Wu, G., Jiang, X., Lee, W.-H., Chen, P.-L.
(2003). Assembly of Functional ALT-associated Promyelocytic Leukemia Bodies Requires Nijmegen Breakage Syndrome 1. Cancer Res.
63: 2589-2595
[Abstract]
[Full Text]
-
Zhao, S., Renthal, W., Lee, E. Y.-H. P.
(2002). Functional analysis of FHA and BRCT domains of NBS1 in chromatin association and DNA damage responses. Nucleic Acids Res
30: 4815-4822
[Abstract]
[Full Text]